Sunday, March 29, 2026
No menu items!
HomeTechnologyHong Kong-listed AI drug discovery company Insilico Medicine and Eli Lilly sign...

Hong Kong-listed AI drug discovery company Insilico Medicine and Eli Lilly sign a drug co-development deal worth up to $2.75B, with $115M in upfront payments (Evelyn Cheng/CNBC)

Featured Podcasts


Lenny’s Podcast:


From skeptic to true believer: How OpenClaw changed my life | Claire Vo

Interviews with world-class product leaders and growth experts to uncover actionable advice to help you build, launch, and grow your own product.


Subscribe to Lenny’s Podcast.


Big Technology Podcast:


Why OpenAI Killed Sora, Did Apple Just Save Siri?, Meta’s Big Loss

The Big Technology Podcast takes you behind the scenes in the tech world featuring interviews with plugged-in insiders and outside agitators.


Subscribe to Big Technology Podcast.


Hard Fork:


The Ezra Klein Show: How Fast Will A.I. Agents Rip Through the Economy?

The future is already here. Each week, journalists Kevin Roose and Casey Newton explore and make sense of the latest in the rapidly changing world of tech.


Subscribe to Hard Fork.


Great Chat:


Bubble talk

A podcast mostly about tech. Brought to you weekly by Angela Du, Sally Shin, Mac Bohannon, Helen Min, and Ashley Mayer.


Subscribe to Great Chat.


Access:


AI takes over meetings, the SF vs London tech scene, and ethics in media

A show about the tech industry’s inside conversation, hosted by tech reporter Alex Heath and founder whisperer Ellis Hamburger.


Subscribe to Access.


Tools and Weapons with Brad Smith:


Everybody Goes Home: How technology is helping prevent wildfires from spreading

Microsoft Vice Chair and President Brad Smith speaks with leaders in government, business, and culture to explore the most critical challenges at the intersection of technology and society.


Subscribe to Tools and Weapons with Brad Smith.

RELATED ARTICLES

Most Popular

Recent Comments